首页|微小RNA-151a-3p对非小细胞肺癌放疗敏感性的影响及其分子机制

微小RNA-151a-3p对非小细胞肺癌放疗敏感性的影响及其分子机制

扫码查看
目的 探讨微小RNA(miR)-151a-3p对非小细胞肺癌放疗敏感性的影响及其分子机制.方法 选取2018年12月至2023年1月我院收治的65例三维适形调强放疗的肺癌样本和癌旁组织作为研究对象,采用荧光定量PCR分析检测放疗敏感组和耐受组肺癌组织中miR-151a-3p的表达水平;人非小细胞肺癌细胞A549分为对照组、miR-151a-3p组和miR-151a-3p抑制剂组,采用miRNA对照、miR-151a-3p模拟物和miR-151a-3p抑制剂转染至细胞,72 h后,分别采用6 MV-X线(6 Gy)照射细胞,采用细胞计数试剂盒(CCK-8)和克隆形成实验分析细胞的增殖能力;采用细胞凋亡检测试剂盒测定细胞的凋亡能力;建立移植瘤裸鼠模型,放疗治疗后,测定肿瘤体积,采用原位缺口末端标记法(TUNEL)染色分析小鼠肿瘤组织细胞凋亡情况,采用蛋白质免疫印迹分析小鼠肿瘤组织组蛋白2A变异体(H2AX)的表达水平.组间比较采用独立样本t检验.结果 三维适形调强放疗敏感肺癌组织miR-151a-3p表达水平(1.53±0.09)低于耐受组织(1.75±0.11),差异有统计学意义(t=9.162,P<0.05).miR-151a-3p组细胞CCK-8吸光度值和细胞克隆形成数量[0.84±0.04、(69.14±5.40)个]低于对照组[1.32±0.06、(107.42±11.01)个],差异有统计学意义(t=18.080、8.259,P<0.05).miR-151a-3p抑制剂组细胞CCK-8吸光度值和细胞克隆形成数量[1.77±0.14、(142.14±10.51)个]高于对照组[1.32±0.06、(107.42±11.01)个],差异有统计学意义(t=7.797、6.033,P<0.05).miR-151a-3p 组细胞凋亡比例[(55.29±7.87)%]高于对照组[(38.93±4.42)%],差异有统计学意义(t=4.792,P<0.05).miR-151a-3p抑制剂组细胞凋亡率[(22.31±11.01)%]低于对照组[(38.93±4.42)%],差异有统计学意义(t=8.513.P<0.05).miR-151a-3p组细胞成瘤体积[(455.31±42.05)mm3]低于对照组[(638.57±36.59)mm3],差异有统计学意义(t=8.698,P<0.05).miR-151a-3p 抑制剂组细胞成瘤体积[(856.87±27.54)mm3]高于对照组[(638.57±36.59)mm3],差异有统计学意义(t=12.610,P<0.05).miR-151a-3p 组细胞和肿瘤组织H2AX表达水平(0.70±0.07、0.54±0.10)低于对照组(0.96±0.07、0.79±0.15),差异有统计学意义(t=6.783、3.609,P<0.05).miR-151a-3p抑制剂组细胞和肿瘤组织H2AX表达水平(1.66±0.12、1.37±0.13)高于对照组(0.96±0.07、0.79±0.15),差异有统计学意义(t=13.190、7.576,P<0.05).结论 miR-151a-3p在非小细胞肺癌呈高表达,其高表达降低放疗敏感性,主要通过H2AX实现的.
Effect of microRNA-151a-3p on radiosensitivity of non-small cell lung cancer and its molecular mechanism
Objective To investigate the effect of microRNA(miRNA,miR)-151a-3p on radio-therapy sensitivity of non-small cell lung cancer and its molecular mechanism.Methods 65 cases of lung cancer samples and adjacent tissues after three-dimensional conformal radiotherapy in our hospital from December 2018 to January 2023 were selected as the research object.The expression levels of miR-151a-3p in lung cancer tissues of the radiotherapy sensitive group and the radiotherapy tolerant group were detected by fluorescence quantitative PCR analysis.Human non-small cell lung cancer A549 cells were divided into control group,miR-151a-3pgroup and miR-151a-3p inhibitor group.The cells were transfected with miR-NA control,miR-151a-3p mimics and miR-151a-3p inhibitors.After 72 h,the cells were irradiated with 6 MV x-ray(6 Gy),and the proliferation ability was analyzed by cell counting kit-8(CCK-8)and clono-genic assay.The apoptotic ability of cells was determined by apoptosis detection kit.The nude mouse mod-el of transplanted tumor was established.After radiotherapy,the tumor volume was measured,the apoptosis of tumor tissues was analyzed by terminal-deoxynucleotidyl transferase mediated nick end labeling(TUNEL)staining,and the expression level of histone family 2A variant(H2AX)in tumor tissues was an-alyzed by Western blotting.The measurement data between groups were compared by independent sample t test.Results The expression level of miR-151a-3p in three-dimensional conformal radiotherapy sensitive lung cancer tissues(1.53±0.09)was significantly lower than that in tolerant tissues(1.75±0.11,t=9.162,P<0.05).The absorbance value of CCK-8 and the number of cell clones in miR-151a-3p group[0.84±0.04,(69.14±5.40)cells]were significantly lower than that in control group[1.32±0.06,(107.42±11.01)cells,t=18.080,8.259,P<0.05].The absorbance value of CCK-8 and the number of cell clones in the miR-151a-3p inhibitor group[1.77±0.14,(142.14±10.51)cells]were significant-ly higher than those in the control group[1.32±0.06,(107.42±11.01)cells,t=7.797,6.033,P<0.05].The proportion of apoptosis in the miR-151a-3p group[(55.29±7.87)%]was significantly higher than that in the control group[(38.93±4.42)%,t=4.792,P<0.05].The apoptosis rate of miR-151a-3p inhibitor group[(22.31±11.01)%]was significantly lower than that of the control group[(38.93±4.42)%,t=8.513,P<0.05].The tumor forming volume of miR-151a-3p group[(455.31±42.05)mm3]was significantly lower than that of the control group[(638.57±36.59)mm3,t=8.698,P<0.05].The tumor forming volume of miR-151a-3p inhibitor group[(855.31±42.05)mm3]was sig-nificantly higher than that of the control group[(638.57±36.59)mm3,t=12.610,P<0.05].The ex-pression level of H2AX in miR-151a-3p group(0.70±0.07,0.54±0.10)was significantly lower than that in the control group(0.96±0.07,0.79±0.15,t=6.783,3.609,P<0.05).The expression level of H2AX in cells and tumor tissues of miR-151a-3p inhibitor group(1.66±0.12,1.37±0.13)was sig-nificantly higher than that in tumor tissues of control group(0.96±0.07,0.79±0.15,t=13.190,7.576,P<0.05).Conclusion MiR-151a-3p is highly expressed in non-small cell lung cancer,and its high expression reduces radiotherapy sensitivity,mainly through H2AX.

Non small cell lung cancerMicroRNA-151a-3pRadiotherapy sensitivity

孙永臣、王晓朦、祖鹏、刘阳、韩文杰

展开 >

商丘市第一人民医院(徐州医科大学临床学院)肿瘤放疗二科,商丘 476100

商丘市第一人民医院(徐州医科大学临床学院)肿瘤综合科,商丘 476100

非小细胞肺癌 微小RNA-151a-3p 放疗敏感性

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(11)